Guizhou Bailing Group Pharmaceutical Co., Ltd. (SHE:002424)

China flag China · Delayed Price · Currency is CNY
3.940
0.00 (0.00%)
May 16, 2025, 3:04 PM CST
-15.99%
Market Cap 5.38B
Revenue (ttm) 3.83B
Net Income (ttm) 33.62M
Shares Out 1.37B
EPS (ttm) 0.02
PE Ratio 197.00
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 12,150,303
Average Volume 17,028,035
Open 4.000
Previous Close 3.940
Day's Range 3.920 - 4.000
52-Week Range 2.980 - 4.720
Beta 0.50
RSI 43.90
Earnings Date Apr 24, 2025

About SHE:002424

Guizhou Bailing Group Pharmaceutical Co., Ltd. research, develops, produces, and sells medicines in China. The company provides medicines in the form of tablets, capsules, granules, syrups, powders, pills, tinctures, sprays, lotions, and cream for cardiovascular and cerebrovascular diseases, cough, cold, pediatric, and gynecologic diseases. Guizhou Bailing Group Pharmaceutical Co., Ltd. was founded in 1999 and is headquartered in Anshun, China. [Read more]

Sector Healthcare
Founded 1999
Employees 6,582
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002424
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.